As of 2025-07-09, the Relative Valuation of Canntab Therapeutics Ltd (PILL.CN) is (0.32) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Canntab Therapeutics Ltd based on Relative Valuation is -6567.8%.
The range of the Relative Valuation is (0.26) - (0.39) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 4.5x | 3.8x |
| Forward P/E multiples | 3.0x - 4.5x | 3.8x |
| Fair Price | (0.26) - (0.39) | (0.32) |
| Upside | -5274.2% - -7861.4% | -6567.8% |
| Date | P/E |